Head/Neck Cancer

Top Story

Monthly cost of oral cancer drugs rises steadily over time

Monthly cost of oral cancer drugs rises steadily over time
April 28, 2016

The cost of oral cancer drugs in their first year on the market has increased significantly since the year 2000, according to a research letter published in JAMA Oncology.

High drug prices can affect patient adherence to cancer therapies and increase the financial burden of medical care, according to Stacie B. Dusetzina, PhD, assistant professor of pharmaceutical outcomes and policy at University of North Carolina Eshelman School of Pharmacy.

In the Journals

Cancer diagnosis increases risk for mental disorders, psychiatric medication use

April 28, 2016
Patients diagnosed with cancer faced an increased risk for common mental disorders — such as depression, anxiety and stress reaction/adjustment disorder —…
In the Journals

Racial, socioeconomic factors associated with pediatric nasopharyngeal cancer diagnosis

April 27, 2016
Factors such as lower socioeconomic status, black race and rural residence appeared associated with an increased risk for a pediatric diagnosis of nasopharyngeal cancer…
In the Journals

Response to therapy assessment effective for dynamic risk stratification in thyroid cancer

April 25, 2016
An assessment of response to therapy in patients with differentiated thyroid cancer treated surgically without radioactive iodine was effective in modifying initial risk…
CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
Video
Meeting News Coverage

Video: TCGA data shows thyroid tumor classification in need of further evaluation

July 11, 2014
More »
Featured
At Issue: Multiple Myeloma Resource Center

At Issue: Multiple Myeloma Resource Center

CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
In the Journals

Monthly cost of oral cancer drugs rises steadily over time

April 28, 2016
The cost of oral cancer drugs in their first year on the market has increased significantly since the year 2000, according to a research letter…
In the Journals

Cancer diagnosis increases risk for mental disorders, psychiatric medication use

April 28, 2016
Patients diagnosed with cancer faced an increased risk for common mental disorders — such as depression, anxiety and stress reaction/adjustment…
In the Journals

Racial, socioeconomic factors associated with pediatric nasopharyngeal cancer diagnosis

April 27, 2016
Factors such as lower socioeconomic status, black race and rural residence appeared associated with an increased risk for a pediatric diagnosis of…
In the Journals

Response to therapy assessment effective for dynamic risk stratification in thyroid cancer

April 25, 2016
An assessment of response to therapy in patients with differentiated thyroid cancer treated surgically without radioactive iodine was effective in…
FDA News

FDA grants breakthrough designation to Opdivo for SCCHN

April 25, 2016
The FDA granted breakthrough therapy designation to nivolumab for the treatment of patients with recurrent or metastatic squamous cell carcinoma of…
Meeting News Coverage

Biden: Realignment of research incentives key to cancer moonshot initiative

April 20, 2016
A redesign of the cancer research enterprise is necessary to accelerate advances and achieve 10 years’ worth of progress in 5 years, Vice…
In the Journals

Noninvasive papillary thyroid carcinoma renamed to remove cancer label

April 20, 2016
Noninvasive thyroid tumors currently diagnosed as encapsulated follicular variant of papillary thyroid carcinoma had a very low probability of…
Meeting News CoveragePerspective

Nivolumab demonstrates efficacy in recurrent, metastatic SCCHN

April 19, 2016
NEW ORLEANS — Treatment with nivolumab improved OS in patients with recurrent or metastatic squamous cell carcinoma of the head and neck…
Meeting News Coverage

LOXO-101 shows promise for solid tumors with NTRK gene fusions

April 18, 2016
NEW ORLEANS — The investigational agent LOXO-101 demonstrated clinical activity in patients with solid tumors that had neurotrophic tyrosine…
Meeting News CoverageVideo

VIDEO: Liquid biopsies valuable but will not eliminate need to assess tumor tissue

April 17, 2016
NEW ORLEANS — Filip Janku, MD, PhD, medical oncologist at The University of Texas MD Anderson Cancer Center, spoke to HemOnc Today about the…
More Headlines »
morganatic-roan morganatic-roan